News and Insights from Our Multidisciplinary Team of Experts
As featured in Pharma Tech Outlook Magazine, July 2020Flagship Biosciences was recently selected as a Top Image Analysis Solution Provider for 2020 by Pharma Tech Outlook Magazine. Flagship’s proprietary tissue image analysis solutions provide both pharmaceutical and...
Brenna O’Neill, Image Analyst for Flagship Biosciences, received her M.S. Ecology and B.S. Marine Biology at Florida Institute of Technology. Brenna knew from a very young age that she would be some kind of scientist. She recently shared more about the early life...
TissueInsight Immuno-Oncology Service Offers Data for Advanced Cancer Patient CareJune 30, 2020 — Flagship Biosciences, providers of expert tissue data insights, today announced the launch of a new clinical diagnostics immuno-oncology service, TissueInsight....
Flagship Biosciences recently hosted a webcast on Biomarkers: Strategies and Implementation, and Drug Development. Introduced by our COO Meredith James, we were pleased to have our colleague Suzana Corritori, MD, PhD, MSc present her thoughts on a strategic approach...
Caroline Chandler, Flagship Project Manager, graduated from Colorado State University with a Bachelor of Science degree in sports medicine. Caroline shared her thoughts about her career and working at Flagship in this spotlight article.Early Cancer Treatment...
Cris Luengo, PhD, is Director of Image Analysis at Flagship Biosciences. Cris has a PhD in Image Analysis and an MSc in Applied Physics, both from Delft University of Technology, The Netherlands. Cris shared some experiences that led him to Flagship, as well as...
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
PUBLICATIONS/POSTERS
BACKGROUND F-06647020, an ADC comprising a humanized monoclonal antibody against PTK7, a cleavable valine-citrulline linker, and an auristatin payload, is being investigated in an ongoing Phase I clinical trial in patients with advanced solid tumors. We hypothesized...
Key Takeaways Manual pathology assessment is challenging and variable, limiting the data interpretation required for meaningful spatial biology analysis Unlike manual assessment, artificial intelligence and machine learning technologies analyze the complex...
Key Takeaways Classifying macrophages is important in understanding response to immunotherapy, but it may be challenging to do by eye Using an immunofluorescence-guided machine learning algorithm provided accurate macrophage classification This algorithm is useful in...
EVENTS
Visit us at booth 821 at the ASGCT Annual Meeting. We help you analyze more data in more depth, so you can produce more effective therapies. Attending the ASGCT Annual Meeting? Schedule a meeting with our team to discuss our: AI-powered digital pathology solutions...
Visit Us at Booth 2866 in the West Building, Level 2 Flagship Biosciences is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the context of disease in order to advance...
Reuniting 100+ leading experts in biotech, pharma, and academia. February 21-23, 2023. We’re headed to Boston to join other leading experts in biotech, pharma and academia to discuss obstacles in clinical trials and strategies for delivering safer and more effective...